Spark Biomedical Inc

We are pleased to announce the launch of our revolutionary research platform: Sparrow Link! At Spark Biomedical, we’re not just advancing neurostimulation research; we’re revolutionizing it. Join the ranks of top institutions like Battelle, Hazelden Betty Ford Foundation, and Medical University of South Carolina who are already using the Sparrow system in their research to push the boundaries of medical science with neurostimulation. Ready to take your research to the next level? Discover how Sparrow Link can transform your research and schedule a consultation today: https://bit.ly/3z51YtD #Innovation #ResearchTools #MedTech

For infants with Neonatal Opioid Withdrawal Syndrome (NOWS), the first days of life are filled with painful challenges. Today, we are proud to share that we’ve completed enrollment for a pivotal clinical trial aimed at offering these newborns a drug-free, non-invasive treatment option. This trial, funded by NIDA under the HEAL Initiative, investigated how transcutaneous auricular neurostimulation (tAN) therapy could reduce the need for prolonged opioid treatment and shorten recovery times.? Read the full press release at https://lnkd.in/gH4sRMA3

The Spark Biomedical team couldn’t be more excited to announce that we have been granted our Medical Device License by Health Canada! Just a few months ago we received?our MDSAP certifications, bolstering our efforts to expand globally. Having our Canadian MDL will allow us to aid millions more people with a stronger start to their opioid recovery journey. Read the official announcement here:?https://lnkd.in/gw2Wnczv

We’re?excited to take another step forward here at?Spark?Biomedical with our new partnership with?electroCore, Inc.!? As?Spark?Biomedical continues to grow,?we're?grateful for the expanding opportunities to support Americans as they embark on their recovery journeys from opioid use disorder. Our CEO,?Daniel Powell, stated,?“By joining forces with electroCore, we can extend our reach and impact, helping more veterans begin their path to recovery with an effective, non-pharmacological option.” To read the full press release, visit: https://lnkd.in/dW5HJ2qF

Excited to announce that our abstract was selected to be presented as part of this year’s Hemostasis & Thrombosis Research Society Symposium! Join Dr. Chris Czura, PhD on March 15th as he presents the findings from our clinical trial work leveraging wearable neurostimulation to accelerate the clotting process in von Willebrand Disease and Heavy Menstrual Bleeding with the #neuraltourniquet. ?? Where: Day 2 // Session 8-C ?? When: March 15th at 8 AM We hope to see you there! #HTRS #HTRS25

We’re just one week away from the 6th Annual Bioelectric Medicine Summit in NY! The Spark Biomedical team is excited to join other leaders in bioelectronic medicine to explore how emerging neurotechnologies are reshaping the healthcare landscape. ?? Be sure to visit us at the Spark Biomedical booth to see transcutaneous auricular neurostimulation in action with a live demo of Sparrow Ascent! #BEMSummit2025 #MedTech

Spark Biomedical is pleased to announce our collaboration with the Air Force's 59th Medical Wing to launch a pioneering trial aimed at enhancing military safety and performance. The study leverages transcutaneous auricular neurostimulation (tAN) therapy to reduce motion sickness and spatial disorientation in military personnel. Read the full press release on our website: https://bit.ly/3XcTSbg

How is your clinic handling MAT/MOUD induction? Navigating precipitated withdrawal is one of the biggest challenges during the induction process. That's where Sparrow Ascent comes in— a wearable neurostimulation device designed to ease patients through MAT/MOUD induction with significantly less discomfort. Book a demo today and see how Sparrow Ascent can help improve your clinic’s withdrawal management protocol: https://bit.ly/3Ywf0Jf #AddictionMedicine #WithdrawalTreatment #OUDtreatment

It's an honor to announce that two of our clinical trial abstracts have been accepted for publication in the American Society of Hematology's Blood Journal. Our first abstract presents a pioneering first-in-human trial to explore the 'neural tourniquet' pathway via transcutaneous auricular neurostimulation (tAN) in healthy subjects. ? The second details a pilot study assessing tAN's safety and efficacy in managing heavy menstrual bleeding in women, with and without underlying bleeding disorders. Contributing these findings to the scientific community is a testament to our commitment to advancing healthcare through innovative neurostimulation technologies. We look forward to sharing the full results soon. Read the abstracts below: Healthy Human:?https://lnkd.in/gMJ7U9y5 Heavy Menstrual Bleeding/Von Willebrand Disease:?https://lnkd.in/gbCXW7DA #Innovation

Just one month to go until the 6th Annual Bioelectric Medicine Summit! At Spark Biomedical, we're gearing up for an incredible event where the brightest minds in bioelectronic medicine will share insights on advancing personalized neurotechnology. ?? Come get a demo at the Spark Biomedical booth! #BEMSummit2025 #MedTech #innovation